新制度下药品集中招标采购制度的完善  

Improvement of Drug Centralized Bidding and Purchase System under the New System

作　　者：刘迎堂 王梅 LIU Ying-Tang;WANG Mei(Hubin Central Health Center,Binzhou 256512,China)

机构地区：[1]博兴县湖滨中心卫生院,山东滨州256512

出　　处：《中国药物经济学》2021年第5期18-21,共4页China Journal of Pharmaceutical Economics

摘　　要：研究分析了药品集中招标采购制度的影响,剖析了药品集中招标采购制度在思想认识、招标评价、招标采购等方面存在的问题,并从提升认识、建立补偿制度、完善评价体系等方面探究了新制度下药品集中招标采购制度的完善对策。The research analyzes the impact of the drug centralized bidding procurement system,the problems of the drug centralized bidding procurement system in terms of ideological understanding,bidding evaluation,and bidding procurement,and explores the perfect countermeasures for the centralized bidding and purchasing system of medicines under the new system from the aspects of enhancing understanding,establishing a compensation system,and improving the evaluation system etc.

关 键 词：新制度 药品集中招标 采购制度 完善对策 

分 类 号：R956[医药卫生—药学]